December 2024's Leading Growth Companies With Insider Stakes

As global markets navigate a mixed economic landscape, with U.S. consumer confidence dipping and major stock indexes experiencing fluctuations, investors are increasingly focusing on growth opportunities that demonstrate resilience and potential. In this context, companies with high insider ownership often attract attention due to the alignment of interests between management and shareholders, suggesting a commitment to long-term success amidst the current market volatility.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Archean Chemical Industries (NSEI:ACI)	22.9%	41.3%
SKS Technologies Group (ASX:SKS)	29.7%	24.8%
Kirloskar Pneumatic (BSE:505283)	30.3%	26.3%
Propel Holdings (TSX:PRL)	23.8%	37.6%
On Holding (NYSE:ONON)	19.1%	29.4%
Plenti Group (ASX:PLT)	12.8%	120.1%
Brightstar Resources (ASX:BTR)	16.2%	84.5%
Fine M-TecLTD (KOSDAQ:A441270)	17.2%	131.1%
Credo Technology Group Holding (NasdaqGS:CRDO)	13.3%	66.3%
Fulin Precision (SZSE:300432)	13.6%	66.7%

Click here to see the full list of 1507 stocks from our Fast Growing Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

CanSino Biologics (SEHK:6185)

Simply Wall St Growth Rating: ★★★★★☆

Overview: CanSino Biologics Inc. is a company that develops, manufactures, and commercializes vaccines in the People's Republic of China with a market cap of HK$11.29 billion.

Operations: The company's revenue segment includes CN¥748.53 million from the research and development of vaccine products for human use.

Insider Ownership: 28.5%

Earnings Growth Forecast: 141.4% p.a.

CanSino Biologics demonstrates strong growth potential with insider ownership, as insiders have shown confidence by buying more shares over the past three months. The company is trading significantly below its estimated fair value and is expected to achieve substantial revenue growth of 33.3% annually, outpacing the Hong Kong market. Recent product developments, including vaccines for polio and diphtheria-tetanus-pertussis, highlight its innovative pipeline. Despite a current net loss, profitability is anticipated within three years.

• Navigate through the intricacies of CanSino Biologics with our comprehensive analyst estimates report here.
• Insights from our recent valuation report point to the potential overvaluation of CanSino Biologics shares in the market.

Ming Yang Smart Energy Group (SHSE:601615)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Ming Yang Smart Energy Group Limited is involved in the R&D, design, manufacture, sale, maintenance, and operation of energy equipment and wind turbines in China with a market cap of CN¥27.63 billion.

Operations: The company generates revenue primarily from its activities in the research, development, design, manufacture, sale, maintenance, and operation of energy equipment and wind turbines in China.

Insider Ownership: 15.8%

Earnings Growth Forecast: 77% p.a.

Ming Yang Smart Energy Group is poised for significant growth, with revenue expected to increase by 21.5% annually, surpassing the Chinese market's average. Despite recent declines in sales and net income—CNY 20.24 billion and CNY 808.51 million respectively—its earnings are forecasted to grow substantially at 77% per year. While insider trading activity has been quiet recently, the company trades at a favorable value compared to industry peers but faces challenges with dividend sustainability due to earnings coverage issues.

• Take a closer look at Ming Yang Smart Energy Group's potential here in our earnings growth report.
• The valuation report we've compiled suggests that Ming Yang Smart Energy Group's current price could be quite moderate.

Shenzhen Senior Technology Material (SZSE:300568)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shenzhen Senior Technology Material Co., Ltd. (SZSE:300568) operates in the manufacturing sector, focusing on producing advanced materials for lithium-ion batteries, with a market cap of approximately CN¥13.41 billion.

Operations: The company generates revenue primarily from its Lithium-Ion Battery Separator New Energy Materials segment, amounting to CN¥3.38 billion.

Insider Ownership: 12.8%

Earnings Growth Forecast: 40.2% p.a.

Shenzhen Senior Technology Material is positioned for substantial growth, with revenue projected to rise by 24.8% annually, outpacing the Chinese market. Despite a decline in net income to CNY 349.37 million from CNY 667.57 million year-on-year, earnings are expected to grow significantly at over 40% per year. The company trades well below its estimated fair value but faces challenges with low profit margins and unsustainable dividends due to insufficient earnings coverage.

• Click here and access our complete growth analysis report to understand the dynamics of Shenzhen Senior Technology Material.
• Our comprehensive valuation report raises the possibility that Shenzhen Senior Technology Material is priced higher than what may be justified by its financials.

Turning Ideas Into Actions

• Discover the full array of 1507 Fast Growing Companies With High Insider Ownership right here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com